Lilly trial shows weight loss with experimental pill flattens over time

Core Insights - Eli Lilly's experimental GLP-1 pill demonstrated an approximate 12% reduction in body weight among participants in a 72-week trial, with weight loss stabilizing for most patients [1] Group 1 - The study results were presented at a recent conference, highlighting the effectiveness of the GLP-1 pill in weight management [1] - The trial duration of 72 weeks indicates a long-term assessment of the drug's impact on weight loss [1] - The plateauing of weight loss suggests that while initial results are promising, further investigation may be needed to understand long-term efficacy [1]